Sukumar Pal Selected Research

mannide monooleate

3/2014	A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.
8/2009	Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
12/2005	Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sukumar Pal Research Topics

Disease

18	Infections 01/2021 - 04/2005
13	Pneumonia (Pneumonitis) 03/2014 - 09/2002
7	Body Weight (Weight, Body) 01/2020 - 09/2002
5	Infertility (Sterility) 01/2020 - 07/2011
2	Reinfection 01/2021 - 06/2009
2	Inflammation (Inflammations) 01/2020 - 01/2014
1	Coinfection 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Gonorrhea 01/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021
1	Syphilis 01/2021
1	Chlamydia Infections 01/2017
1	Weight Loss (Weight Reduction) 04/2016
1	Trachoma 06/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2008

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 01/2021 - 09/2002
11	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 09/2002
4	AntigensIBA 01/2021 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2010
3	CpG ODN 1826IBA 03/2014 - 12/2005
3	mannide monooleateIBA 03/2014 - 12/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	Subunit VaccinesIBA 01/2020 - 07/2011
2	Dihydrotachysterol (AT 10)IBA 03/2014 - 07/2004
2	OligodeoxyribonucleotidesIBA 10/2009 - 09/2002
2	OvalbuminIBA 10/2009 - 09/2002
1	Immunodominant EpitopesIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Histocompatibility Antigens Class IIIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 04/2016
1	Adenosine Triphosphatases (ATPase)IBA 04/2016
1	EpitopesIBA 06/2014
1	PAM2-CSK4IBA 03/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 07/2013
1	Acetates (Acetic Acid Esters)FDA Link 03/2013
1	Progesterone FDA LinkGeneric 03/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	Cholera ToxinIBA 10/2009
1	Monoclonal AntibodiesIBA 12/2008
1	Immunoglobulin G (IgG)IBA 12/2008
1	AntibodiesIBA 12/2008
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 02/2006
1	Cysteine (L-Cysteine)FDA Link 04/2005
1	DisulfidesIBA 04/2005
1	OspA proteinIBA 03/2003
1	aluminum sulfate (alum)IBA 09/2002
1	Freund's AdjuvantIBA 09/2002